戻る Agenda
Session 2: Hospital exemption – European Level Discussions and National Practices
Session Chair(s)
Alexander Natz, JD
Secretary General
European Confederation of Pharmaceutical Entrepreneurs, Belgium
Session 2: Hospital Exemption – European Level Discussions and National Practices
Speaker(s)
Representative:
Pietro Sternini
Atara Biotherapeutics, Switzerland
Head of Market Access Europe
Representative:
Ilona Reischl, PhD, MPharm
Austrian Medicines and Medical Devices Agency (AGES MEA), Austria
Biologics Quality Assessor
Representative:
Michela Gabaldo, PharmD, MSc
Evotec, Italy
VP ATMP Global Regulatory Affairs